Skip to main content

Table 1 Baseline demographic characteristics

From: The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo-controlled trial

 

Iodine (n = 29)

Placebo (n = 30)

Age at trial entry, yearsa

29.1 (5.7)

29.8 (5.1)

Gestational age at trial entry, weeksa

15.2 (2.6)

14.9 (2.4)

Primiparousb

13 (44.8)

13 (43.3)

Completed secondary educationb

20 (69.0)

22 (73.3)

Completed further educationb

22 (75.9)

24 (80.0)

Smoke at trial entry or leading up to pregnancyb

7 (24.1)

5 (16.7)

Miscarriage in previous pregnancyb

8 (27.6)

12 (40.0)

Previous or current depressionb

4 (13.8)

7 (23.3)

BMI at trial entrya

25.3 (5.9)

23.6 (3.9)

Pre-pregnancy BMIa

23.6 (5.5)

22.2 (4.3)

Infant sex: maleb

20 (71.4)

9 (31.0)

  1. BMI body mass index
  2. aData are presented as mean (standard deviation)
  3. bData are presented as number (percentage)